Provided by Tiger Trade Technology Pte. Ltd.

Madrigal Pharmaceuticals

511.70
-5.0450-0.98%
Volume:67.67K
Turnover:34.63M
Market Cap:11.80B
PE:-35.99
High:517.00
Open:517.00
Low:507.18
Close:516.74
52wk High:615.00
52wk Low:393.61
Shares:23.06M
Float Shares:13.73M
Volume Ratio:0.29
T/O Rate:0.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-14.2164
EPS(LYR):-12.8501
ROE:-53.31%
ROA:-17.84%
PB:22.53
PE(LYR):-39.82

Loading ...

Madrigal Grants 4,676 Inducement RSUs to 13 New Employees Under 2025 Plan

Reuters
·
Aug 21

Madrigal Pharmaceuticals Announces Grants of Inducement Awards Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 21

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 21

Madrigal Pharmaceuticals (MDGL) Stock May Look Cheap On Sales But Risky On Cash Flow

Simply Wall St.
·
Aug 20

Madrigal Pharma Director John C. Reed Files Initial Beneficial Ownership Statement

Reuters
·
Aug 19

Madrigal Extends Resmetirom Into Pediatric MASH, Boosting Long-Term Upside for MDGL

TIPRANKS
·
Aug 14

Madrigal Pharmaceuticals Adds Renowned Leader to Board

TIPRANKS
·
Aug 12

Madrigal Appoints J&J R&D Chief John Reed to Board

Reuters
·
Aug 12

Madrigal Appoints John C. Reed, M.d., Ph.d., to Its Board of Directors

THOMSON REUTERS
·
Aug 12

Press Release: Madrigal Appoints John C. Reed, M.D., Ph.D., to Its Board of Directors

Dow Jones
·
Aug 12

Madrigal Pharmaceuticals Grants 4,263 Inducement RSUs to 10 New Employees

Reuters
·
Aug 07

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 07

Madrigal Pharmaceuticals to Present at Canaccord Genuity Annual Growth Conference

Reuters
·
Aug 06

Arrowhead Pharmaceuticals Q3 Revenue Jumps on Redemplo Growth

Reuters
·
Aug 05

Madrigal upgraded to Outperform from Peer Perform at Wolfe Research

TIPRANKS
·
Aug 04

Madrigal Pharmaceuticals is Maintained at Overweight by Barclays

Dow Jones
·
Aug 03

Madrigal Pharmaceuticals price target lowered to $962 from $964 at Barclays

TIPRANKS
·
Aug 03

Movement Alert|Madrigal Pharmaceuticals Falls 5.07% in Regular Trading, Q2 Earnings Loss Widening Extends Selling Pressure

Market Focus
·
Jul 31

Madrigal Pharmaceuticals Inc : Bofa Global Research Cuts Price Objective to $543 from $553

THOMSON REUTERS
·
Jul 31

Neurocrine Biosciences Q2 Adjusted EPS Beats Expectations, Revenue Rises on Product Portfolio Growth

Reuters
·
Jul 31